Yatharth Hospital & Trauma Care Services YATHARTH
NCR and western UP hospital chain (Noida, Greater Noida, Noida Extension, Faridabad, Jhansi, Agra) serving value-conscious and government-scheme patients
Mapped in 1 theme: Hospitals & Healthcare.
Where Yatharth Hospital & Trauma Care Services sits in the supply chain
Yatharth Hospital & Trauma Care Services appears in 1 supply-chain layer in one theme, Hospitals & Healthcare.
Hospitals & Healthcare › Multi-specialty hospital chains
OperatorOther companies in this layer
Revenue and profit
| ₹ Cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 375 | 478 | 635 | 886 | 1,207 |
| Net profit | 44 | 66 | 114 | 131 | 170 |
Latest-year revenue ₹1,207 Cr (FY26, company-wide).
Strengths
- Fast bed growth through acquisitions of hospitals in tier-2 cities (Agra, Faridabad)
- High share of CGHS/ECHS and scheme patients made it a direct gainer from the Oct 2025 CGHS rate revision
- Low cost per bed versus metro chains
Risks
- Lower ARPOB than metro super-specialty chains
- Government receivables stretch working capital
- Acquired hospitals need upgrading before they earn like the core units
Common questions
What does Yatharth Hospital & Trauma Care Services do?
NCR and western UP hospital chain (Noida, Greater Noida, Noida Extension, Faridabad, Jhansi, Agra) serving value-conscious and government-scheme patients.
Where does Yatharth Hospital & Trauma Care Services sit in the supply chain?
Yatharth Hospital & Trauma Care Services (NSE: YATHARTH) is mapped in 1 supply-chain layer: Multi-specialty hospital chains (Hospitals & Healthcare).
Who are Yatharth Hospital & Trauma Care Services' peers?
In the Multi-specialty hospital chains layer of Hospitals & Healthcare: Apollo Hospitals Enterprise, Max Healthcare Institute, Manipal Health Enterprises (Manipal Hospitals), Fortis Healthcare, Global Health (Medanta), Narayana Hrudayalaya (Narayana Health) and 5 more.
What is Yatharth Hospital & Trauma Care Services' market cap and valuation?
As of 6 Nov 2026: market cap ₹9,885 Cr, P/E 51.9x, ROCE 12.9%, ROE 10.2%, dividend yield 0.05%.